Commercial · National

UnitedHealthcare

UnitedHealthcare publishes coverage policies for 4 of the 4 sleep apnea treatments we track. Each is linked to its source document below.

By treatment

CPAP and PAP therapy

Policy published

Policy number — 2026T0525UU

Effective — 2026-04-01

Prior authorisation — Not stated in the policy we found

Try another treatment first — Not stated

Read the policy document →

Oral appliance therapy

Policy published

Policy number — 2026T0525UU

Effective — 2026-04-01

Prior authorisation — Not stated in the policy we found

Try another treatment first — Yes

The treating clinician must document PAP treatment failure, intolerance, or refusal before oral-appliance therapy under the published policy.

Read the policy document →

Hypoglossal nerve stimulation

Policy published

Policy number — 2026T0525UU

Effective — 2026-04-01

Prior authorisation — Not stated in the policy we found

Try another treatment first — Yes

PAP must have lacked therapeutic efficacy, been refused, or been intolerable before HNS under the adult criteria.

Read the policy document →

Tirzepatide (Zepbound) for OSA

Policy published

Policy number — 2025 P 1475-2

Effective — 2026-03-01

Prior authorisation — Required

Try another treatment first — Yes

For OSA, the policy requires either continued OSA symptoms despite documented PAP adherence or documentation that the patient is not a PAP candidate.

Read the policy document →

Last verified 2026-08-15. We record structured facts and link the source; we do not reproduce policy text. The document itself governs.

Your specific plan may differ from UnitedHealthcare's general policy, particularly if your coverage is through an employer. Policies are revised without notice. Nothing here is a guarantee of coverage or a substitute for confirming with your plan.